Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Assets Average (2016 - 2025)

Historic Assets Average for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to $238.5 million.

  • Lifecore Biomedical, Inc. \De\'s Assets Average fell 463.13% to $238.5 million in Q2 2025 from the same period last year, while for May 2025 it was $238.5 million, marking a year-over-year decrease of 463.13%. This contributed to the annual value of $246.7 million for FY2025, which is 279.86% down from last year.
  • Lifecore Biomedical, Inc. \De\'s Assets Average amounted to $238.5 million in Q2 2025, which was down 463.13% from $246.5 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s Assets Average's 5-year high stood at $504.4 million during Q2 2021, with a 5-year trough of $238.5 million in Q2 2025.
  • For the 5-year period, Lifecore Biomedical, Inc. \De\'s Assets Average averaged around $311.5 million, with its median value being $253.7 million (2023).
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Assets Average skyrocketed by 1958.2% in 2021, and later plummeted by 4283.99% in 2022.
  • Lifecore Biomedical, Inc. \De\'s Assets Average (Quarter) stood at $433.0 million in 2021, then tumbled by 37.38% to $271.2 million in 2022, then decreased by 9.39% to $245.7 million in 2023, then increased by 2.19% to $251.1 million in 2024, then dropped by 5.01% to $238.5 million in 2025.
  • Its Assets Average stands at $238.5 million for Q2 2025, versus $246.5 million for Q1 2025 and $251.1 million for Q4 2024.